Josh Snow

Josh Snow is Trailhead’s Chief Commercial Officer. Josh was most recently Executive Director of Therapeutics Commercial Operations at Fujifilm Cellular Dynamics (FCDI), where he oversaw commercial partnerships and growth strategies for FCDI’s stem cell therapy CDMO business.

Prior to that, Josh served as Director of Business Development and Marketing Strategy at Mirus Bio, now part of MilliporeSigma. At Mirus, he helped spearhead the strategic launch of products for entry into the GMP viral vector manufacturing market, paving the way for its acquisition by Gamma Biosciences in 2021.

Josh holds a PhD in Cellular and Molecular Biology from the University of Wisconsin-Madison.